Koji Ishida

Director/Board Member presso Sumitomo Pharma America, Inc.

76 anni

Health Technology

Distribution Services

Government

Profilo

Koji Ishida is currently a Director at Sumitomo Pharma America, Inc. He previously worked as a Director at Bank of Japan from 2011 to 2016 and as an Independent Outside Director at Sumitomo Corp.
Mr. Ishida completed his undergraduate degree at the Graduate School of Economics University of Tokyo in 1970.

Posizioni attive di Koji Ishida

Società	Posizione	Inizio
Sumitomo Pharma America, Inc. Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA.	Director/Board Member	-

Tutte le posizioni attive di Koji Ishida

Precedenti posizioni note di Koji Ishida

Società	Posizione	Fine
BANK OF JAPAN	Director/Board Member	29/06/2016
SUMITOMO CORPORATION	Director/Board Member	-

Vedi nel dettaglio l'esperienza di Koji Ishida

Formazione di Koji Ishida

Graduate School of Economics University of Tokyo

Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Koji Ishida

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	2
SUMITOMO CORPORATION	Distribution Services
BANK OF JAPAN	Government

Aziende private	1
Sumitomo Pharma America, Inc. Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA.	Health Technology